Growth hormone treatment for adults with Prader-Willi syndrome
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study tests whether giving growth hormone to adults with Prader-Willi syndrome can improve their health and well-being. The goal is to see if the treatment is safe and helpful for adults with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a doctor-confirmed genetic diagnosis of Prader-Willi syndrome.
- You must not be pregnant.
- You must not have any current cancer.
- Your diabetes must be well controlled (HbA1c below 8%).
- You must not have untreated sleep apnea (with more than 5 pauses per hour).
- Your body mass index (BMI) must be below 40.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called BMB-101 to see if it can help reduce the constant hunger (hyperphagia) that is common in Prader-Willi syndrome. The trial will check how safe and effective the drug is, and if it works, it may offer a new treatment option.
This trial tests an investigational drug called CSTI-500 for people with Prader-Willi syndrome who are in the hyperphagia (constant hunger) phase. It aims to see if the drug can improve behavior and reduce overeating. You and your caregiver will need to visit the clinic regularly and answer questions about symptoms.
This trial studies whether taking prebiotics and probiotics can help children with Prader-Willi syndrome manage obesity. It’s testing a gut-focused approach to weight control over the study period.
This study tests if growth hormone can safely help children who are shorter than average for their age and gender. It is for children with certain conditions that cause short stature.
This trial tests an oral medication called GS3-007a for children who have not yet reached puberty and have growth hormone deficiency. The goal is to see if it helps them grow taller.
This trial tests a new growth hormone treatment called GenSci134 in healthy adults and adults with growth hormone deficiency (AGHD). The goal is to see if it is safe and effective for people who need growth hormone replacement.
Hear when a new Prader-Willi Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.